What is OS Therapies's non-cash interest expense?

OS Therapies (OSTX) reported non-cash interest expense of $68.97K in Q1 2026.

How has OS Therapies's non-cash interest expense changed year-over-year?

OS Therapies's non-cash interest expense increased by 106.1% year-over-year, from -$1.12M to $68.97K.

OS Therapies OSTX Non-cash interest expense

Non-cash interest expense at other companies

Five9FIVN

$187K-29.7%

Kyverna Therapeutics, Inc.KYTX

$114K—

Laureate Education, Inc.LAUR

$593K+56.1%

Mediaco Holding Inc.MDIA

$1.5M+5.9%

Carriage ServicesCSV

$146K+5.8%

TDA

USA TODAY Co., Inc.TDAY

$1.51M-66.6%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's non-cash interest expense?: OS Therapies (OSTX) reported non-cash interest expense of $68.97K in Q1 2026.
How has OS Therapies's non-cash interest expense changed year-over-year?: OS Therapies's non-cash interest expense increased by 106.1% year-over-year, from -$1.12M to $68.97K.